… The objective of this study was to assess immunogenicity, reactogenicity and safety of a …
diphtheria and tetanus and >96.0% of participants were seropositive for anti-pertussis antibodies…

… Data on reactogenicity and immunogenicity, particularly after repeated Tdap, are … reduced
antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix) is immunogenic …

… Summary of reactogenicity and safety following administration of a Tdap dose (total … of
reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix) is immunogenic …

… immunogenicity in such patients. We performed a meta-analysis on 5 clinical trials in adults
receiving reduced-antigen tetanus-diphtheria-acellular … immunogenicity and reactogenicity …

… persistence of antibodies against diphtheria and tetanus at 5 … antibody concentrations above
the assay cut-offs. Similarly, a … information on the immunogenicity, reactogenicity and safety …

… It is unlikely that these reactions were due to recent exposure to Tetanus or Diphtheria …
Tetanus or Diphtheria vaccines within 5 y from study start. However, BioNet's TdaP reactogenicity …

… Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content
diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy …

… regarding acceptance, reactogenicity and immunogenicity of maternal … Reactogenicity
data were compared with data from a randomized controlled trial that studied immunogenicity …

… A cohort study examining reactogenicity of Tdap in pregnant women included only … reduced
antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic …

… ; compared the immunogenicity of MenACWY-TT when given before and after Tdap, and of
Tdap when given before and after MenACWY-TT; and assessed the reactogenicity and safety …